Cargando…

Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021

Background: The abuse of antibiotics during the SARS-CoV-2 pandemic might have disrupted efforts to curb the further development and spread of the antimicrobial resistance of Staphylococcus aureus infection and Staphylococcus spp. coagulase-negative (CoNS) agents of nosocomial bloodstream infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Serra, Nicola, Di Carlo, Paola, Andriolo, Maria, Mazzola, Giovanni, Diprima, Elena, Rea, Teresa, Anastasia, Antonio, Fasciana, Teresa Maria Assunta, Pipitò, Luca, Capra, Giuseppina, Giammanco, Anna, Cascio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305610/
https://www.ncbi.nlm.nih.gov/pubmed/37374138
http://dx.doi.org/10.3390/life13061356
_version_ 1785065775089844224
author Serra, Nicola
Di Carlo, Paola
Andriolo, Maria
Mazzola, Giovanni
Diprima, Elena
Rea, Teresa
Anastasia, Antonio
Fasciana, Teresa Maria Assunta
Pipitò, Luca
Capra, Giuseppina
Giammanco, Anna
Cascio, Antonio
author_facet Serra, Nicola
Di Carlo, Paola
Andriolo, Maria
Mazzola, Giovanni
Diprima, Elena
Rea, Teresa
Anastasia, Antonio
Fasciana, Teresa Maria Assunta
Pipitò, Luca
Capra, Giuseppina
Giammanco, Anna
Cascio, Antonio
author_sort Serra, Nicola
collection PubMed
description Background: The abuse of antibiotics during the SARS-CoV-2 pandemic might have disrupted efforts to curb the further development and spread of the antimicrobial resistance of Staphylococcus aureus infection and Staphylococcus spp. coagulase-negative (CoNS) agents of nosocomial bloodstream infections (NBSIs). The purpose of our work was to study the resistance patterns of Staphylococcus aureus and CoNS through the analysis of blood cultures in hospitalized SARS-CoV-2-positive and SARS-CoV-2-negative patients (pts.). Materials and methods: During the period January 2018–June 2021, a retrospective case–control study was performed on blood cultures positive for Staphylococcus spp. detected in 177 adult pts. (≥18 years old) hospitalized for >48 hours at Sant’Elia Hospital, Caltanissetta. Results: Staphylococcus aureus was isolated in 33.9% of blood culture samples, and among CoNS, the most frequent strains were Staphylococcus capitis (18.6%) and Staphylococcus hominis (18.1%). Patients aged ≥ 65 years, with a greater number of males, comprised the SARS-CoV-2-negative pts. (71.8% vs. 52.2%, p = 0.0154). Among the SARS-CoV-2-positive patients, the significant resistance of Staphylococcus aureus was only observed for erythromycin (57.1%). The oxacillin resistance of Staphylococcus capitis was higher in SARS-CoV-2-positive than in negative pts. (90% and 78.3%, respectively). Comparing the two groups, we found an increase in resistance in SARS-CoV-2-negative patients for the following antibiotics: gentamicin for Staphylococcus aureus (p = 0.007), clindamycin and erythromycin (p = 0.012) for Staphylococcus hominis and oxacillin and rifampicin for Staphylococcus haemoliticus (p = 0.012). Conclusions: Our study confirms the relevance of oxacillin-resistant Staphylococcus aureus in being responsible for bloodstream infection and draws attention to highly oxacillin-resistant CoNS such as Staphylococcus capitis. The presence of resistant strains of CoNS in hospitals can be worrying, as it limits treatment options and worsens outcomes. The Infection Control Committee (ICC) recommends new treatment strategies to decrease colonization and infections. As part of the implementation of a bloodstream infection prevention program, the authors encourage the introduction of a report on the antimicrobial resistance of hospital bacteremia due to CoNS.
format Online
Article
Text
id pubmed-10305610
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103056102023-06-29 Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021 Serra, Nicola Di Carlo, Paola Andriolo, Maria Mazzola, Giovanni Diprima, Elena Rea, Teresa Anastasia, Antonio Fasciana, Teresa Maria Assunta Pipitò, Luca Capra, Giuseppina Giammanco, Anna Cascio, Antonio Life (Basel) Article Background: The abuse of antibiotics during the SARS-CoV-2 pandemic might have disrupted efforts to curb the further development and spread of the antimicrobial resistance of Staphylococcus aureus infection and Staphylococcus spp. coagulase-negative (CoNS) agents of nosocomial bloodstream infections (NBSIs). The purpose of our work was to study the resistance patterns of Staphylococcus aureus and CoNS through the analysis of blood cultures in hospitalized SARS-CoV-2-positive and SARS-CoV-2-negative patients (pts.). Materials and methods: During the period January 2018–June 2021, a retrospective case–control study was performed on blood cultures positive for Staphylococcus spp. detected in 177 adult pts. (≥18 years old) hospitalized for >48 hours at Sant’Elia Hospital, Caltanissetta. Results: Staphylococcus aureus was isolated in 33.9% of blood culture samples, and among CoNS, the most frequent strains were Staphylococcus capitis (18.6%) and Staphylococcus hominis (18.1%). Patients aged ≥ 65 years, with a greater number of males, comprised the SARS-CoV-2-negative pts. (71.8% vs. 52.2%, p = 0.0154). Among the SARS-CoV-2-positive patients, the significant resistance of Staphylococcus aureus was only observed for erythromycin (57.1%). The oxacillin resistance of Staphylococcus capitis was higher in SARS-CoV-2-positive than in negative pts. (90% and 78.3%, respectively). Comparing the two groups, we found an increase in resistance in SARS-CoV-2-negative patients for the following antibiotics: gentamicin for Staphylococcus aureus (p = 0.007), clindamycin and erythromycin (p = 0.012) for Staphylococcus hominis and oxacillin and rifampicin for Staphylococcus haemoliticus (p = 0.012). Conclusions: Our study confirms the relevance of oxacillin-resistant Staphylococcus aureus in being responsible for bloodstream infection and draws attention to highly oxacillin-resistant CoNS such as Staphylococcus capitis. The presence of resistant strains of CoNS in hospitals can be worrying, as it limits treatment options and worsens outcomes. The Infection Control Committee (ICC) recommends new treatment strategies to decrease colonization and infections. As part of the implementation of a bloodstream infection prevention program, the authors encourage the introduction of a report on the antimicrobial resistance of hospital bacteremia due to CoNS. MDPI 2023-06-09 /pmc/articles/PMC10305610/ /pubmed/37374138 http://dx.doi.org/10.3390/life13061356 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Serra, Nicola
Di Carlo, Paola
Andriolo, Maria
Mazzola, Giovanni
Diprima, Elena
Rea, Teresa
Anastasia, Antonio
Fasciana, Teresa Maria Assunta
Pipitò, Luca
Capra, Giuseppina
Giammanco, Anna
Cascio, Antonio
Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
title Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
title_full Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
title_fullStr Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
title_full_unstemmed Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
title_short Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
title_sort staphylococcus aureus and coagulase-negative staphylococci from bloodstream infections: frequency of occurrence and antimicrobial resistance, 2018–2021
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305610/
https://www.ncbi.nlm.nih.gov/pubmed/37374138
http://dx.doi.org/10.3390/life13061356
work_keys_str_mv AT serranicola staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT dicarlopaola staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT andriolomaria staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT mazzolagiovanni staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT diprimaelena staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT reateresa staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT anastasiaantonio staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT fascianateresamariaassunta staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT pipitoluca staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT capragiuseppina staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT giammancoanna staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021
AT cascioantonio staphylococcusaureusandcoagulasenegativestaphylococcifrombloodstreaminfectionsfrequencyofoccurrenceandantimicrobialresistance20182021